Time-resolved in situ assembly of the leukotriene-synthetic 5-lipoxygenase/5-lipoxygenase-activating protein complex in blood leukocytes

FASEB Journal

Volumn 30, Issue 1, 2016, Pages 276-285

  Gerstmeier, Jana ^a   Weinigel, Christina ^b   Rummler, Silke ^b   Rådmark, Olof ^c   Werz, Oliver ^a   Garscha, Ulrike ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Eicosanoids; Inflammation; Lipoxygenases; Proximity ligation assay

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; ARACHIDONIC ACID; CALCIMYCIN; LEUKOTRIENE; VELIFLAPON; ALOX5AP PROTEIN, HUMAN; ARACHIDONATE 5 LIPOXYGENASE; PROTEIN BINDING;

ARTICLE; CELL NUCLEUS MEMBRANE; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; LEUKOCYTE; MONOCYTE; NEUTROPHIL; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; ADULT; CELL CULTURE; CELL MEMBRANE; HEK293 CELL LINE; METABOLISM; PROTEIN TRANSPORT;

5-LIPOXYGENASE-ACTIVATING PROTEINS; ADULT; ARACHIDONATE 5-LIPOXYGENASE; ARACHIDONIC ACID; CELL MEMBRANE; CELLS, CULTURED; FEMALE; HEK293 CELLS; HUMANS; LEUKOCYTES; PROTEIN BINDING; PROTEIN TRANSPORT;

EID: 84973459133     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.15-278010     Document Type: Article

References (48)

1. Peters-Golden, M., and Henderson, W. R., Jr. (2007) Leukotrienes. N. Engl. J. Med. 357, 1841-1854
2. Wang, D., and Dubois, R. N. (2010) Eicosanoids and cancer. Nat. Rev. Cancer 10, 181-193
3. Serhan, C. N. (2014) Pro-resolving lipid mediators are leads for resolution physiology. Nature 510, 92-101
4. Samuelsson, B. (1983) Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220, 568-575
5. Panossian, A., Hamberg, M., and Samuelsson, B. (1982) On the mechanism of biosynthesis of leukotrienes and related compounds. FEBS Lett. 150, 511-513
6. Werz, O., Bürkert, E., Fischer, L., Szellas, D., Dishart, D., Samuelsson, B., Rådmark, O., and Steinhilber, D. (2003) 5-Lipoxygenase activation by MAPKAPK-2 and ERKs. Adv. Exp. Med. Biol. 525, 129-132
7. Hammarberg, T., Provost, P., Persson, B., and Rådmark, O. (2000) The N-terminal domain of 5-lipoxygenase binds calcium and mediates calcium stimulation of enzyme activity. J. Biol. Chem. 275, 38787-38793
8. Wong, A., Cook, M. N., Foley, J. J., Sarau, H. M., Marshall, P., and Hwang, S. M. (1991) Influx of extracellular calcium is required for the membrane translocation of 5-lipoxygenase and leukotriene synthesis. Biochemistry 30, 9346-9354
9. Kargman, S., Vickers, P. J., and Evans, J. F. (1992) A23187-induced translocation of 5-lipoxygenase in osteosarcoma cells. J. Cell Biol. 119, 1701-1709
10. Rouzer, C. A., and Samuelsson, B. (1985) On the nature of the 5-lipoxygenasereaction in human leukocytes: enzyme purification and requirement for multiple stimulatory factors. Proc. Natl. Acad. Sci. USA 82, 6040-6044
11. Rakonjac, M., Fischer, L., Provost, P.,Werz, O., Steinhilber, D., Samuelsson, B., and Rådmark, O. (2006) Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production. Proc. Natl. Acad. Sci. USA 103, 13150-13155
12. Basavarajappa, D., Wan, M., Lukic, A., Steinhilber, D., Samuelsson, B., and Rådmark, O. (2014) Roles of coactosin-like protein (CLP) and 5-lipoxygenase-activating protein (FLAP) in cellular leukotriene biosynthesis. Proc. Natl. Acad. Sci. USA 111, 11371-11376
13. Dixon, R. A., Diehl, R. E., Opas, E., Rands, E., Vickers, P. J., Evans, J. F., Gillard, J. W., and Miller, D. K. (1990) Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis. Nature 343, 282-284
14. Abramovitz, M., Wong, E., Cox, M. E., Richardson, C. D., Li, C., and Vickers, P. J. (1993) 5-lipoxygenase-activating protein stimulates the utilization of arachidonic acid by 5-lipoxygenase. Eur. J. Biochem. 215, 105-111
15. Gerstmeier, J., Weinigel, C., Barz, D., Werz, O., and Garscha, U. (2014) An experimental cell-based model for studying the cell biology and molecular pharmacology of 5-lipoxygenase-activating protein in leukotriene biosynthesis. Biochim. Biophys. Acta 1840, 2961-2969
16. Mancini, J. A., Abramovitz, M., Cox, M. E., Wong, E., Charleson, S., Perrier, H., Wang, Z., Prasit, P., and Vickers, P. J. (1993) 5-lipoxygenase-activating protein is an arachidonate binding protein. FEBS Lett. 318, 277-281
17. Ferguson, A. D., McKeever, B. M., Xu, S., Wisniewski, D., Miller, D. K., Yamin, T. T., Spencer, R. H., Chu, L., Ujjainwalla, F., Cunningham, B. R., Evans, J. F., and Becker, J. W. (2007) Crystal structure of inhibitor-bound human 5-lipoxygenase-activating protein. Science 317, 510-512
18. Rouzer, C. A., Ford-Hutchinson, A. W., Morton, H. E., and Gillard, J. W. (1990) MK886, a potent and specific leukotriene biosynthesis inhibitor blocks and reverses the membrane association of 5-lipoxygenase in ionophore-challenged leukocytes. J. Biol. Chem. 265, 1436-1442
19. Strid, T., Svartz, J., Franck, N., Hallin, E., Ingelsson, B., Söderström, M., and Hammarström, S. (2009) Distinct parts of leukotriene C(4) synthase interact with 5-lipoxygenase and 5-lipoxygenase activating protein. Biochem. Biophys. Res. Commun. 381, 518-522
20. Mandal, A. K., Jones, P. B., Bair, A. M., Christmas, P., Miller, D., Yamin, T. T., Wisniewski, D., Menke, J., Evans, J. F., Hyman, B. T., Bacskai, B., Chen, M., Lee, D. M., Nikolic, B., and Soberman, R. J. (2008) The nuclear membrane organization of leukotriene synthesis. Proc. Natl. Acad. Sci. USA 105, 20434-20439
21. Pergola, C., Dodt, G., Rossi, A., Neunhoeffer, E., Lawrenz, B., Northoff, H., Samuelsson, B., Rådmark, O., Sautebin, L., and Werz, O. (2008) ERK-mediated regulation of leukotriene biosynthesis by androgens: a molecular basis for gender differences in inflammation and asthma. Proc. Natl. Acad. Sci. USA 105, 19881-19886
22. Pergola, C., Rogge, A., Dodt, G., Northoff, H., Weinigel, C., Barz, D., Rådmark, O., Sautebin, L., and Werz, O. (2011) Testosterone suppresses phospholipase D, causing sex differences in leukotriene biosynthesis in human monocytes. FASEB J. 25, 3377-3387
23. Werz, O., Bürkert, E., Samuelsson, B., Rådmark, O., and Steinhilber, D. (2002) Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes. Blood 99, 1044-1052
24. Söderberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius, K. J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F., Larsson, L. G., and Landegren, U. (2006) Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 3, 995-1000
25. Pergola, C., Gerstmeier, J., Mönch, B., Çalişkan, B., Luderer, S., Weinigel, C., Barz, D., Maczewsky, J., Pace, S., Rossi, A., Sautebin, L., Banoglu, E., and Werz, O. (2014) The novel benzimidazole derivative BRP-7 inhibits leukotriene biosynthesis in vitro and in vivo by targeting 5-lipoxygenase-activating protein (FLAP). Br. J. Pharmacol. 171, 3051-3064
26. Kulkarni, S., Das, S., Funk, C. D., Murray, D., and Cho, W. (2002) Molecular basis of the specific subcellular localization of the C2-like domain of 5-lipoxygenase. J. Biol. Chem. 277, 13167-13174
27. Werz, O. (2002) 5-lipoxygenase: cellular biology and molecular pharmacology. Curr. Drug Targets Inflamm. Allergy 1, 23-44
28. Bair, A. M., Turman, M. V., Vaine, C. A., Panettieri, R. A., Jr., and Soberman, R. J. (2012) The nuclear membrane leukotriene synthetic complex is a signal integrator and transducer. Mol. Biol. Cell 23, 4456-4464
29. Martinez Molina, D., Eshaghi, S., and Nordlund, P. (2008) Catalysis within the lipid bilayer-structure and mechanism of the MAPEG family of integral membrane proteins. Curr. Opin. Struct. Biol. 18, 442-449
30. Gillard, J., Ford-Hutchinson, A. W., Chan, C., Charleson, S., Denis, D., Foster, A., Fortin, R., Leger, S., McFarlane, C. S., Morton, H., et al. (1989) L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Can. J. Physiol. Pharmacol. 67, 456-464
31. Carter, G. W., Young, P. R., Albert, D. H., Bouska, J., Dyer, R., Bell, R. L., Summers, J. B., and Brooks, D. W. (1991) 5-lipoxygenase inhibitory activity of zileuton.J. Pharmacol. Exp. Ther. 256, 929-937
32. Seno, K., Okuno, T., Nishi, K., Murakami, Y., Watanabe, F., Matsuura, T., Wada, M., Fujii, Y., Yamada, M., Ogawa, T., Okada, T., Hashizume, H., Kii, M., Hara, S., Hagishita, S., Nakamoto, S., Yamada, K., Chikazawa, Y., Ueno, M., Teshirogi, I., Ono, T., and Ohtani, M. (2000) Pyrrolidine inhibitors of human cytosolic phospholipase A (2). J. Med. Chem. 43, 1041-1044
33. Müller-Peddinghaus, R., Fruchtmann, R., Ahr, H. J., Beckermann, B., Bühner, K., Fugmann, B., Junge, B., Matzke, M., Kohlsdorfer, C., Raddatz, S., et al. (1993) BAY X1005, a new selective inhibitor of leukotriene synthesis: pharmacology and pharmacokinetics. J. Lipid Mediat. 6, 245-248
34. Brash, A. R. (2001) Arachidonic acid as a bioactive molecule. J. Clin. Invest. 107, 1339-1345
35. Radmark, O., Werz, O., Steinhilber, D., and and Samuelsson, B. (2015) 5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease. Biochim. Biophys. Acta. 1851, 331-339
36. Surette, M. E., Dallaire, N., Jean, N., Picard, S., and Borgeat, P. (1998) Mechanisms of the priming effect of lipopolysaccharides on the biosynthesis of leukotriene B4 in chemotactic peptide-stimulated human neutrophils. FASEB J. 12, 1521-1531
37. Schaible, A. M., Koeberle, A., Northoff, H., Lawrenz, B., Weinigel, C., Barz, D., Werz, O., and Pergola, C. (2013) High capacity for leukotriene biosynthesis in peripheral blood during pregnancy. Prostaglandins Leukot. Essent. Fatty Acids 89, 245-255
38. Rådmark, O., Werz, O., Steinhilber, D., and Samuelsson, B. (2007) 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem. Sci. 32, 332-341
39. Werz, O., and Steinhilber, D. (2005) Development of 5-lipoxygenase inhibitors - lessons from cellular enzyme regulation. Biochem. Pharmacol. 70, 327-333
40. Powell, W. S. (1984) Properties of leukotriene B4 20-hydroxylase from polymorphonuclear leukocytes. J. Biol. Chem. 259, 3082-3089
41. Shak, S., and Goldstein, I. M. (1984) Omega-oxidation is the major pathway for the catabolism of leukotriene B4 in human polymorphonuclear leukocytes. J. Biol. Chem. 259, 10181-10187
42. Rouzer, C. A., and Kargman, S. (1988) Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187. J. Biol. Chem. 263, 10980-10988
43. Lepley, R. A., and Fitzpatrick, F. A. (1994) Irreversible inactivation of 5-lipoxygenase by leukotriene A4. Characterization of product inactivation with purified enzyme and intact leukocytes. J. Biol. Chem. 269, 2627-2631
44. Aharony, D., Redkar-Brown, D. G., Hubbs, S. J., and Stein, R. L. (1987) Kinetic studies on the inactivation of 5-lipoxygenase by 5 (S)-hydroperoxyeicosatetraenoic acid. Prostaglandins 33, 85-100
45. De Carolis, E., Denis, D., and Riendeau, D. (1996) Oxidative inactivation of human 5-lipoxygenase in phosphatidylcholine vesicles. Eur. J. Biochem. 235, 416-423
46. Allain, E. P., Boudreau, L. H., Flamand, N., and Surette, M. E. (2015) The intracellular localisation and phosphorylation profile of the human 5-lipoxygenase Δ13 isoform differs from that of its full length counterpart. PLoS One 10, e0132607
47. Flamand, N., Lefebvre, J., Surette, M. E., Picard, S., and Borgeat, P. (2006) Arachidonic acid regulates the translocation of 5-lipoxygenase to the nuclear membranes in human neutrophils. J. Biol. Chem. 281, 129-136
48. Vickers, P. J., Adam, M., Charleson, S., Coppolino, M. G., Evans, J. F., and Mancini, J. A. (1992) Identification of amino acid residues of 5-lipoxygenase-activating protein essential for the binding of leukotriene biosynthesis inhibitors. Mol. Pharmacol. 42, 94-102